HYFT
MINDWALK HLDG (HYFT)
NASDAQ
$1.81-$0.16 (-7.92%)
Price as of Jun 03, 2026 7:11 PM EDT
  • $82.2M
    Market Cap
  • N/A
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$1.67
$1.99
$1.97
1-Year Range
$1.02
$2.78
$1.97
Latest Close$1.97
Change
+$0.23 (+11.68%)
Volume688,240
Market Cap$82.2M
Shares Outstanding46.7M
P/E (TTM)-1.93
Diluted EPS (TTM)-$0.91
Enterprise Value$71.5M

Information as of 06/02/2026

Company Profile

MINDWALK HOLDINGS CORP
MINDWALK HOLDINGS CORP
https://www.mindwalkai.com
$82.2M
Market Cap
-$30.2M
Net Income
Sector: Healthcare
Industry: Biotechnology
Industrious 823 Congress Ave, Austin, TX, United States, 78701
800 620 4187

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Key Executives

  • Richard Scott Areglado
  • Jennifer Lynne Bath
  • Kari Graber
  • Shuji Sato
  • Dirk Van Hyfte

Current Ownership Distribution

  • Other31.9M (68.24%)
  • Institutions13.3M (28.48%)
  • Insiders1.4M (3.06%)
  • Mutual Funds100,000 (0.21%)